The KHENERGYC Study

NCT04846036 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic company decision - not related to safety concerns

Conditions

Mitochondrial Diseases
Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation
MELAS
Subacute Necrotizing Encephalomyelopathy

Interventions

DRUG: Sonlicromanol
DRUG: Placebo

Sponsor

Khondrion BV

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]